Biocon Biologics has announced US FDA approval for Kirsty (Insulin Aspart-xjhz, 100 units/mL). It's an extremely important development as Kirsty is the first and only interchangeable biosimilar to NovoLog, a rapid-acting insulin brand...
The InfinityLab Pro iQ Series mass detectors were launched by Agilent Technologies in India. The series is designed for next-generation liquid chromatography-mass detection (LC-MS) and aims to improve how impurities, trace contaminants, and complex
In a landmark deal that will transform diabetes care in India, Emcure Pharmaceuticals has entered an exclusive partnership with Sanofi India to sell and distribute some of Sanofi's most established oral anti-diabetic (OAD) products in the country...
An appeal has been made to the Prime Minister by Sumanata Kumar Tiwari, the joint director-cum-drug controller of Jharkhand, for a significant overhaul of the current regulatory framework to combat the escalating menace of counterfeit medicines
.png)
PharmaJet has signed a strategic Memorandum of Understanding with Egypt’s Unified Procurement Authority (UPA) and leading pharmaceutical company EVA Pharma to enable introduction of needle-free vaccine delivery as part of their routine...
India’s pharmaceutical sector is focused on a major goal of increasing exports to USD 1 trillion, and biosimilars are emerging as the cornerstone of this growth. Currently valued at USD 50–55 billion, pharmaceutical exports from India are expected...
In a bold strategic shift, Wockhardt has divested its U.S. generics business to focus on high-value, innovative therapies, including novel antibiotics and biologics. The company announced the voluntary liquidation of Wockhardt USA LLC and Morton...
In a landmark move for India's biopharma industry, Ichnos Glenmark Innovation (IGI)—a partnership between Glenmark Pharmaceuticals and Ichnos Sciences—has signed a USD 2 billion licensing deal with AbbVie, a leading US pharmaceutical company...
Sun Pharmaceutical Industries is working toward a complete regulatory resolution for three of its manufacturing facilities that are being reviewed by the US Food and Drug Administration (USFDA). Sun Pharmaceutical has completed way of corrective...
In a remarkable move, Nectar Lifesciences announced the sale of its core active pharmaceutical ingredients (API), formulations and menthol business to Ceph Lifesciences Pvt Ltd, a total consideration of Rs 1,290 crore. The transaction includes a...
.jpg)
, CDSCO.jpg)